Actinium Pharmaceuticals, Inc. (ATNM)
Operating Cash Flow Growth
26.16%
TTM · Period ending:
ATNM Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported26.16%period ending
Latest reported26.16%period ending
ATNM TTM Cash from Operations YoY % (25.21% → 26.16%)
Year-over-year change
High-resolution chart · PNG
ATNM operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 26.1599% | |
| 31.2455% | |
| 25.6773% | |
| 28.063% | |
| 9.6257% | |
| 16.0476% | |
| 30.132% | |
| 26.903% | |
| 19.5485% | |
| -5,978.5276% | |
| -647.6053% | |
| -518.8478% | |
| -467.1653% | |
| 96.896% | |
| 141.4262% | |
| 151.5132% | |
| 153.5292% | |
| 1.8687% | |
| 3.4741% | |
| -8.3584% | |
| -2.4032% | |
| 1.9282% | |
| -0.7248% | |
| 1.7767% | |
| 3.583% | |
| -5.9434% | |
| -4.3284% | |
| -6.6068% | |
| -16.2743% | |
| 4.789% | |
| 4.5575% | |
| 14.0238% | |
| 16.2015% | |
| -1.0742% | |
| -3.6755% | |
| -10.3012% | |
| -21.0611% | |
| -22.4193% | |
| -12.109% | |
| -4.513% | |
| 9.4523% | |
| 1.0394% | |
| -29.2361% | |
| -84.362% | |
| -153.7407% | |
| -173.0766% | |
| -128.0325% | |
| -4.9281% | |
| 5.8724% | |
| 13.9382% | |
| -20.7129% | |
| -52,589.2345% | |
| -40,448.8825% | |
| -154,580.971% | |
| -175,117.1429% | |
| -429.8844% | |
| -58.1084% | |
| -153.1896% | |
| -137.9706% | |
| -137.226% | |
| -175.0917% | |
| 165.4797% | |
| 141.7133% | |
| 152.3179% | |
| 196.8823% | |
| 34.0157% | |
| -34.5102% | |
| -20.8563% | |
| -19.9829% | |
| -40.5075% | |
| 9.8632% | |
| -2.9473% | |
| 25.2086% |